Table 1.
Patient characteristics and clinical biomarkers
| Anthropometric Data | |
| Sex, M/F | 3 M/13 F |
| Age, yr | 73 ± 10 |
| Height, cm | 165 ± 12 |
| Weight, kg | 97 ± 23 |
| BMI, kg/m2 | 35 ± 6 |
| BSA, m2 | 2.1 ± 0.3 |
| Heart rate, beats/min | 66 ± 10 |
| Mean arterial pressure, mmHg | 89 ± 11 |
| Clinical biomarkers | |
| BNP, pg/mL | 70 ± 20 |
| NT-proBNP, pg/mL | 914 ± 249 |
| ST2, ng/mL | 50 ± 7 |
| Galectin-3, ng/mL | 15 ± 1 |
| Cystatin C, ng/mL | 19 ± 1 |
Values are means ± SD. BMI, body mass index; BNP, B-type natriuretic peptide; BSA, body surface area; NT-proBNP, NH2-terminal pro-B-type natriuretic peptide; ST2, suppression of tumorigenicity 2.